Insider trades
Marino Garcia, CEO of Dianthus Therapeutics DNTH, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $10M. The latest trade was on 03/16.
Marino Garcia
CEO and President
- Company
- Dianthus Therapeutics DNTH
- First filing
- 24/01/26
- Trades
- 16 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$10M
- Last trade
- 03/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DNTH | Open-market sale10b5-1 plan | 03/12 | 03/13 | 122,918 sh5 trades | $81.49avg. | $10,016,380.63 | −100.0% |